학술논문
Real-world study of the efficacy and safety of belantamab mafodotin (GSK2857916) in relapsed or refractory multiple myeloma based on data from the nominative ATU in France: the IFM 2020-04 study
Document Type
Article
Author
Talbot, A.; Arnulf, B.; Bobin, A.; Leleu, X.; Tabone, L.; Boccaccio, C.; Deal, C.; Lambert, J.; Petillon, M.-O.; Allangba, O.; Agape, P.; Arnautou, P.; Belkhir, R.; Cailleres, S.; Chaoui, D.; Chrétien, M.-L.; Decaux, O.; Schulmann, S.; Frenzel, L.; Gastaud, L.; Huart, A.; Hulin, C.; Karlin, L.; Laribi, K.; Le Calloch, R.; Lenain, P.; Macro, M.; Manier, S.; Montes, L.; Moreau, S.; Moreau, P.; Touzeau, C.; Morel, V.; Norwood, J.; Piocelle, F.O.; Perrot, A.; Pica, G.M.; Rey, P.; Schmitt, A.; Stoppa, A.-M.; Tiab, M.; Vidal, V.; Vignon, M.; Vincent, L.; Van De Wyngaert, Z.; Zarnitsky, C.; Kerbouche, N.; Paka, P.; Avet-Loiseau, H.
Source
In: Haematologica . (Haematologica, October 2023, 108(10):2774-2782)
Subject
Language
English
ISSN
15928721
03906078
03906078